Chronic alcohol abuse has a detrimental effect on the brain and liver. There is no effective treatment for these patients, and the mechanism underlying alcohol addiction and consequent alcohol-induced damage of the liver/brain axis remains unresolved. We compared experimental models of alcoholic liver disease (ALD) and alcohol dependence in mice and demonstrated that genetic ablation of IL-17 receptor A (IL-17ra–/–) or pharmacological blockade of IL-17 signaling effectively suppressed the increased voluntary alcohol drinking in alcohol-dependent mice and blocked alcohol-induced hepatocellular and neurological damage. The level of circulating IL-17A positively correlated with the alcohol use in excessive drinkers and was further increased in patients with ALD as compared with healthy individuals. Our data suggest that IL-17A is a common mediator of excessive alcohol consumption and alcohol-induced liver/brain injury, and targeting IL-17A may provide a novel strategy for treatment of alcohol-induced pathology.
Jun Xu, Hsiao-Yen Ma, Xiao Liu, Sara Rosenthal, Jacopo Baglieri, Ryan McCubbin, Mengxi Sun, Yukinori Koyama, Cedric G. Geoffroy, Kaoru Saijo, Linshan Shang, Takahiro Nishio, Igor Maricic, Max Kreifeldt, Praveen Kusumanchi, Amanda Roberts, Binhai Zheng, Vipin Kumar, Karsten Zengler, Donald P. Pizzo, Mojgan Hosseini, Candice Contet, Christopher K. Glass, Suthat Liangpunsakul, Hidekazu Tsukamoto, Bin Gao, Michael Karin, David A. Brenner, George F. Koob, Tatiana Kisseleva
Title and authors | Publication | Year |
---|---|---|
Interleukin-6 related signaling pathways as the intersection between chronic diseases and sepsis
Yang J, Yang L, Wang Y, Huai L, Shi B, Zhang D, Xu W, Cui D |
Molecular Medicine | 2025 |
Clinical Trial to Assess the Safety and Tolerability of Anti-IL 23 Monoclonal Antibody Guselkumab in Patients With Alcohol-Associated Liver Disease.
Diaz LA, Morris S, Dave S, Kim SM, Sarik W, Richards L, Madamba E, Bettencourt R, Fulinara C, Pham T, Miller G, Carvalho-Gontijo Weber R, Momper JD, He F, Jain S, Jamieson C, Kisseleva T, Brenner D, Loomba R |
Alimentary pharmacology & therapeutics | 2025 |
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy.
Seyhan D, Allaire M, Fu Y, Conti F, Wang XW, Gao B, Lafdil F |
Cellular & molecular immunology | 2025 |
Novel RORγt inverse agonists limit IL-17-mediated liver inflammation and fibrosis
Dabbaghizadeh A, Dion J, Maali Y, Fouda A, Bédard N, Evaristo G, Hassan GS, Tchervenkov J, Shoukry NH |
The Journal of Immunology Author Choice | 2025 |
Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats
Floris G, Dabrowski KR, Zanda MT, Daws SE |
2024 | |
Inflammation in Alcohol-Associated Hepatitis: Pathogenesis and Therapeutic Targets
Feng D, Hwang S, Guillot A, Wang Y, Guan Y, Chen C, Maccioni L, Gao B |
Cellular and Molecular Gastroenterology and Hepatology | 2024 |
IL17RB genetic variants are associated with acamprosate treatment response in patients with alcohol use disorder: A proteomics-informed genomics study
Ho MF, Zhang C, Cohan JS, Tuncturk M, Heider RM, Coombes BJ, Biernacka J, Moon I, Skime M, Ho AM, Ngo Q, Skillon C, Croarkin PE, Oesterle TS, Karpyak VM, Li H, Weinshilboum RM |
Brain, Behavior, and Immunity | 2024 |
Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease
Abdelnabi MN, Hassan GS, Shoukry NH |
Frontiers in Immunology | 2024 |
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention.
Rabiu L, Zhang P, Afolabi LO, Saliu MA, Dabai SM, Suleiman RB, Gidado KI, Ige MA, Ibrahim A, Zhang G, Wan X |
Journal of gastroenterology | 2024 |
Cell-to-cell and organ-to-organ crosstalk in the pathogenesis of alcohol-associated liver disease
Gao H, Jiang Y, Zeng G, Huda N, Thoudam T, Yang Z, Liangpunsakul S, Ma J |
eGastroenterology | 2024 |
Gut-liver Axis: Recent Concepts in Pathophysiology in Alcohol-Associated Liver Disease
Raya Tonetti F, Eguileor A, Mrdjen M, Pathak V, Travers J, Nagy LE, Llorente C |
Hepatology (Baltimore, Md.) | 2024 |
Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats
Floris G, Dabrowski KR, Zanda MT, Daws SE |
Molecular Psychiatry | 2024 |
Pre-clinical and clinical evidence for suppression of alcohol intake by apremilast
Kolter Grigsby, Regina Mangieri, Amanda Roberts, Marcelo Lopez, Alexander Tran, Evan Firsick, Kayla Townsley, Alan Beneze, Jessica Bess, Toby K. Eisenstein, Joseph Meissler, John Light, Jenny Miller, Susan Quello, Farhad Shadan, Michael Skinner, Heather Aziz, Pamela Metten, Richard Morissett, John Crabbe, Marisa Roberto, Howard Becker, Barbara Mason, Angela Ozburn |
Journal of Clinical Investigation | 2023 |
A Pathogenic Role of Non-Parenchymal Liver Cells in Alcohol-Associated Liver Disease of Infectious and Non-Infectious Origin.
Kharbanda KK, Chokshi S, Tikhanovich I, Weinman SA, New-Aaron M, Ganesan M, Osna NA |
Biology | 2023 |
Sex differences in depression: An immunological perspective
Kropp DR, Hodes GE |
Brain Research Bulletin | 2023 |
Dihydromyricetin supplementation improves ethanol-induced lipid accumulation and inflammation
Janilkarn-Urena I, Idrissova A, Zhang M, VanDreal M, Sanghavi N, Skinner SG, Cheng S, Zhang Z, Watanabe J, Asatryan L, Cadenas E, Davies DL |
Frontiers in Nutrition | 2023 |
Maternal and Adult Interleukin-17A Exposure and Autism Spectrum Disorder
M Fujitani, H Miyajima, Y Otani, X Liu |
Frontiers in Psychiatry | 2022 |
Chronic and Binge Alcohol Ingestion Increases Truncated Oxidized Phosphatidylcholines in Mice Lungs Due to Increased Oxidative Stress
Appolonia CN, Wolf KM, Zawatsky CN, Cinar R |
Frontiers in physiology | 2022 |
Innate immune activation: Parallels in alcohol use disorder and Alzheimer’s disease
Ramos A, Joshi RS, Szabo G |
Frontiers in molecular neuroscience | 2022 |
Interplay Between Liver Type 1 Innate Lymphoid Cells and NK Cells Drives the Development of Alcoholic Steatohepatitis
Cheng C, Zhang Q, Li Y, Jiang J, Xie L, Shen H, Wu D, Zhang H, Zhang H, Wang X, Wu H, Xu J, Gui L, Li B, Ju C, Peng H, Yin S, Xu L |
Cellular and Molecular Gastroenterology and Hepatology | 2022 |
A perspective of intestinal immune-microbiome interactions in alcohol-associated Liver Disease
R Bruellman |
International journal of biological sciences | 2021 |
Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis
Y Li, J Zhang, J Shi, K Liu, X Wang, Y Jia, T He, K Shen, Y Wang, J Liu, W Zhang, T Wang, Z Zheng, D Hu |
Stem Cell Research & Therapy | 2021 |
IL-17 in the Pathogenesis of Disease: Good Intentions Gone Awry
S Majumder, MJ McGeachy |
Annual Review of Immunology | 2021 |
Emerging Roles of T Cells in the Pathogenesis of Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
P Hirsova, AO Bamidele, H Wang, D Povero, XS Revelo |
Frontiers in Endocrinology | 2021 |
Synaptic effects of IL-1β and CRF in the central amygdala after protracted alcohol abstinence in male rhesus macaques
R Patel, F Varodayan, M Herman, V Jimenez, R Agnore, L Gao, M Bajo, V Carlson, N Walter, S Fei, K Grant, M Roberto |
Neuropsychopharmacology | 2021 |
Immunopathobiology and therapeutic targets related to cytokines in liver diseases
Y He, S Hwang, YA Ahmed, D Feng, N Li, M Ribeiro, F Lafdil, T Kisseleva, G Szabo, B Gao |
Cellular and Molecular Immunology | 2020 |
Immune Response to an Acute Moderate Dose of Alcohol in Healthy Young Adults
MA Monnig, PS Lamb, JM Parra, PA Cioe, CM Martone, PM Monti, G Szabo |
Alcohol and Alcoholism | 2020 |
Effects of Tacrolimus and Other Immune Targeting Compounds on Binge-Like Ethanol Drinking in High Drinking in the Dark Mice
KB Grigsby, AM Savarese, P Metten, BJ Mason, YA Blednov, JC Crabbe, AR Ozburn |
2020 | |
Alcohol dependence promotes systemic IFN-γ and IL-17 responses in mice
K Frank, S Abeynaike, R Nikzad, RR Patel, AJ Roberts, M Roberto, S Paust, J Wang |
PloS one | 2020 |